Biotechnological Drugs Market

Biotechnological Drugs Market contains market size and forecasts of Biotechnological Drugs in Global, including the following market information:

Global Biotechnological Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biotechnological Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Genetically Engineered Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biotechnological Drugs include 3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical, Cadila Healthcare, Celgen Biopharma, Celltrion, Dr Reddy?s and GeneScience Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Biotechnological Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biotechnological Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biotechnological Drugs Market Segment Percentages, by Type, 2021 (%)

• Genetically Engineered Drugs
• Therapeutic Monoclonal Antibody Drugs
• Gene Therapy and Nucleic Acid Drugs
• Genetically Engineered Vaccines
• Other

Global Biotechnological Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biotechnological Drugs Market Segment Percentages, by Application, 2021 (%)

• Tumor
• Autoimmune Disease
• Other

Global Biotechnological Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biotechnological Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Biotechnological Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Biotechnological Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 3SBIO
• Anhui Anke Biotechnology
• Beijing SL Pharmaceutical
• Biotech Pharmaceutical
• Cadila Healthcare
• Celgen Biopharma
• Celltrion
• Dr Reddy?s
• GeneScience Pharmaceuticals
• Hisun Pharma
• Jiangsu Sihuan Bioengineering
• Novartis (Sandoz)
• Pfizer (Hospira)
• Shanghai Lansheng Guojian Pharmaceutical
• Shenzhen Neptunus Interlong Bio-Technique
• Tonghua Dongbao Pharmaceutical
• Torrent Pharmaceuticals